Detection of Na+/H+ exchanger mRNA in human neutrophils and lymphocytes using the polymerase chain reaction  by Quednau, Beate et al.
Volume 289. number 2. 221-223 FEBS 10142 
Q 1991 Federation of European Biochemical Socielies UUl45793/4l/S3.~0 
ADONIS 001457939100854D 
September 1991 
Detection of Na+/W exchanger mRNA in human neutrophils and 
lymphocytes using the polymerase chain reaction 
Beate Quednau’, Dieter Rosskopf’, Hartmut Weiler-GUttIe? and Winfried Siffert’ 
’ Ma.\--Pirack-Iturirur fiir Biopltysik. Kennedyallee 70, D-6000 Frattkflitrr/Main 70. Gerntan_v and 21nslimt fir Biochettzie der 
Techniscitett Hochsclrule Dartmad;, D-6100 Darttatadr, German_v 
Received 2 I May 1991; revised version received 9 July 1991 
‘Using the reverse polymerase chain reaction (RT-PCR). we have examined the expression of Na’/H’ exchanger mRNA in human huffy coat 
preparations. lymphocytes and neutrophils. Total RNA from all cell types was reverse transcribed specifically and then amplified by PCR. The 
identity of the PCR products was confirmed by restriction enzyme analysis and hybridization with a specific oligonucleotide probe. The detection 
of low abundance Na’/H’ antiporter specific transcripts by RT-PCR in different human blood cells ex vivo should facilitate future studies on 
regulatory and pathophysiological aspects of Na’/H’ exchanger mRNA expression in human cells and tissue samples. 
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1. INTRODUCTION 
Regulation UT intracellular pH (pHi) in vertebrate 
cells is ensured by a specific ion transport system termed 
the Na’/H” exchanger which provides an electroneutral 
exchange of intracellular H’ for extracellular Na’. This 
ion transport serves a variety of cellular functions, e.g. 
pHi - homeostasis, control of cell volume and regulation 
of cell proliferation [I]. The activity of the Na’/H+ ex- 
changer is enhanced after cell stimulation. e.g. by 
growth factors most likely by phosphorylation of a re- 
gulatory site in a protein kinase C-dependent reaction 
(for reviews see e.g. [1,2). 
Although the human amiloride-sensitive Na’/H’ ex- 
changer has recently been cloned from transformed 
mouse fibroblasts [3j, the actual expression of Na’/H’ 
antiporter-specific mRNA in human cells and tissues 
remained to be demonstrated. 
We investigated the functional presence of Na’/H’ 
exchange in human lymphocytes and neutrophils and 
the expression of Nab/H’ antiporter-specific mRNA in 
these blood cells by use of the reverse transcription 
polymerase chain reaction (RT-PCR). 
2. MATERIALS AND METHODS 
2. I. Prepcrrctriott of h/out/ cells 
Blood (100 ml) was obtained from human volunteers and anticoagu- 
lated with 20% (v/v) acid-citrate-dextrose (75 mM sodium citrate, 38 
mM citric acid and 138 mM glucose). Neutrophils were isolated from 
whole blood after dcxtran sedimentation and hypotonic 1ysis using 
standard methods [5]. Lymphocytes wcrc isolated by centrifugation 
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through Ficoll Hypaque (Pharmacia LKB. Uppsala, Sweden) [6]. 
Buffy coat preparations from human blocid concentrates were kindly 
provided by Dr Walter, German Red Cross Blood Transfusion 
Center. Hagen. Germany. 
2.2. Measrtrotlert! of Na’/H’ e.rchatge 
Cells were suspended in HEPES buffer (140 mM NaCI, 5 mM #Cl, 
5 mM KHzP04, I mM MgSO,, IO mM HEPES (Na’-free), 5 mM 
glucose. pH 7.4. and incubated with 2OpM ofthe pH-sensitive fluores- 
cent dye 2’,7’-bis(carboxyethyl)-5.6-carboxy-fluoresccin acetoxymet- 
hylestcr (BCECF-AM; Molecular Probes, Oregon, USA) for 30 min 
at 37°C. BCECF-loaded cells were transferred to a cuvette containing 
2 ml of HEPES buffer to yield a final concenlration of 1 x IO’ cells/ml 
and prewarmed to 37°C. The fluorescence of BCECF was recorded 
in a KONTRON SFM 25 spectrofluorimeter (Kontron, Diisseldorf, 
Germany) equipped with a thermostatted cuvette holder as previously 
described [7]. Na’/H’ exchange was activated by the addition of Na’- 
propionate solution. pH 7.4, to a final concentration of 30 mM. 
2.3. Preparariotl of RNA 
Total RNA was isolated from huffy coat preparations and granulo- 
cytes using the guanidinium thiocyanale method including purifica- 
tion of the RNA by CsCl-gradient ccntrifugation [8]. Total RNA from 
lymphocytes was isolated using the method of Chomczynski and 
Sacchi [9]. 
2.4. Syrhe~is of cDNA 
One microgram of total RNA was reverse transcribed specifically 
at 37°C for 60 min with 200 U of Moloney urine leukemia virus 
(M-MLV) reverse transcriptase (BRL, Gaithersburg. USA) and the 
following reagents (in a total volume of 100 ~1): 1 x reaction buffer 
(50 mM Tris-HCI pH 8.3.75 mM KC]. IOmM DTT, I.5 mM MgCI,); 
IO pmol primer I; 25 LJ RNase inhibitor (Boehringer, Mannheim, 
Germany); I mM dATP. dGTP, dCTP, dTTP, respectively. The reac- 
tion was stopped by heating the solution to 9S”C for 5 min. The tubes 
were then cooled to 4°C and stored on ice or frozen until used. 
2.5. Oligonucleorides 
Oligonucleotide primers (see Table I) were synthesized by the phos- 
phoramidite solid-phase method on an Applied Biosystems Model 
380A synthesizer. Primer I (used for cDNA synthesis) is comple- 
mentary to bases 384 to 368 of the human antiporter cDNA sequence 
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Fig. 1. Representative curves showing pHi recovery from artificial 
cytosolic acidification. (A) human lymphocytes; (B) human neutro- 
phils. Na+-propionate (Prop), 30 mM, was added at the arrows. The 
displayed curves arc representative of 8 experiments each. 
i3]. Primer II is complementary to bases 351 to 334 of the human 
cDNA and primer III is identical to bases -3 to +2l. Primer III 
additionally carries an artificial BumHI site and a stuffer comprising 
4 nucleotidcs. The sequence flanked by primers II and III contains a 
single NspV site (TTCGAA). Oligonucleotide IV was used for Sou- 
thern blot hybridization of the PCR products. It is complementary to 
bases 145 to 128 of the human cDNA sequence. 
2.6. Pol_vmernse ckain reaction (PCR) 
PCR was carried out as described by Kawasaki and Wang [IO] and 
Doherty et al. [I I ] with minor modifications. One-tenth volume of the 
cDNA reaction mixture was amplified in a total volume of 50 ~1 
containing I x PCR buffer (SO mM KCI. 20 mM Tris-HCI pH 8.3. 1.5 
mM MgC&. 0.1 me/ml BSA), 200 PM dATP. dCTP, dGTP. dTTP. 
respectively, I mM DTT. IO pmol primer 11, IO pmol primer III. 
Samples were heated first to 94°C for 5 min before 2.5 U of Taq 
DNA-Polymerase (Perkin- Elmer-Cetus) were added and the reaction 
mixture was overlaid with 40 ~1 mineral oil (Sigma, St. Louis, USA). 
PCR was carried out in a programmable heater (Biomed. Obertheres. 
Germany). Amplification was performed for 40 cycles, each cycle 
consisting of denaturation at 94°C (30 s), annealing at 60°C (I min). 
and elongation at 72°C (90 s). All samples were kept on ice or frozen 
until analyzed. 
A blank was prepared using all of the reagents including 200 ng of 
RNA and the Na’/H’ antiporter PCR primers II and III. 
2.7. Restriction etcynrr atu!vsis 
8 ~1 of each PCR reaction mixture was ethanol-precipitated, redis- 
solved in 10~1 water and incubated with 10 U of the restriction enzyme 
NspV and the corresponding 10x buffer (Biozym, Hameln. Germany) 
for I h at 50°C (25 yl. final volume) before another 10 U of the enzyme 
were added for one more hour. The samples were separated on a I mm 
8% polyacrylamide gel using pBR 3221HorIII fragments as size stan- 
dards. 
2.8. Southem blot hybridixrtion 
7 ,uI of each PCR reaction was separated on a 2% agarose gel and 
the DNA was blotted onto GeneScreen membrane (DuPont NEN. 
Boston, USA). Hybridization occurred at 51°C for IG h in a solution 
containing 6x SSC, 3x Denhardt’s solution, 1.0% SDS, 100 pglml 
denatured herring sperm DNA with 5x10’ cpm/ml of the labelcc! 
oligonucleotideprobe IV. 5’-Phosphorylation of theprobe wascarried 
out using [t”P]ATP and T4 polynucleotide kinase (BRL, Gai- 
thersburg, USA). Filters were washed four times in 6x SSC, 0. I% SDS 
at 51°C for IO min, one time in 2x SSC. 0.1% SDS at 51°C for 5 min, 
and exposed to Kodak X-AR film for I6 h. 
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Fig. 2. Detection of Na*/H’ exchanger-specific mRNA in human 
blood cells by XT-PCR and restriction fragment analysis of the PCR 
products. Lane 1, size standard: lane 2. buffy coat: lane 3. lymphocy 
tes: lane 4. neutrophils. Lanes 5-7 display the PCR products after 
digestion with NspV. Lane 5. buffy coat: lane 6. lymphocytes: lane i. 
neutrophils. Lane 8. blank. Samples were separated on a I mm 8% 
polyacrylamide gel using pRR 322lH(teIII fragments as size standard. 
3. RESULTS AND DISCUSSION 
The recovery of pHi from acidification in neutrophils 
and lymphocytes is depicted in Fig. 1. Both cell types 
acidified upon the addition of propionate and. thereaf- 
ter, pHi gradually returned to its initial value. This 
response was inhibited both after removal of extracellu- 
far sodium (not shown) or in the presence of 20 PM 
EIPA which confirms the presence of a Na’/H’ exchan- 
ger in neutrophils and lymphocytes (for review see [4]). 
Next we examined the expression of the Na’/H* anti- 
porter mRNA in human blood cells. Total RNA from 
buffy coat. lymphocytes. and neutrophils was reverse- 
transcribed specifically and the resulting cDNA was 
subjected to amplification by PCR. The obtained PCR 
products are shown in Fig. 2. After amplification a 
single major DNA band was obtained in each lane. The 
size of these bands corresponds to the predicted length 
of 364 bp as deduced from a suitable standard size 
marker. The identity of the PCR products as amplified 
human Na’/H’ exchanger-specific DNA was confir- 
med first by restriction enzyme analysis using NspV (see 
section 2). which yielded two fragments of the expected 
Table 1 
Oligonucleotides corresponding to tbc human Na’/H’ eschangcr 
cDN.4 sequence 
Oligonucleotide 
P:imrr ! (cDi\lA) 
Primer 2 (PCR) 
Primer 3 (PCR) 
Oligo 4 
(hybridization) 
Sequence (S-+3’) 
GATGCTTGAGATAGTGG 
TATCTTCATGAGGCAGCC 
GATCGGATCCAC- 
CATGGTTCTGCGGTCTGGCATC 
AGCTTCGAATGGTGCTGG 
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Fig. 3. Southern blot hybridization of RT-PCR products with a Na-/ 
H’ antiporter-specific oligonucleotide probe. (A) PCR products after 
amplification of cDNAs: (B) autoradiograph of a corresponding Sout- 
hem blot after hybridization with oligonucleotide 4 (cf. Table I). Lane 
I, size standards; lanes 2 and 5, buffy coat: lanes 3 and 6. neutrophils; 
lanes 4 and 7. lymphocytes. The PCR products were separated on an 
ethidium bromide-stained 2% agarose gel using SPPIIEcoRI frag- 
ments as size standard. 
size (213 and 151 bp). The weak DNA bands on the 
same level as the unrestricted products result from a 
non-complete digestion of the cDNA. Subsequently, the 
PCR products were separated on a 2% agarose gel and 
analyzed by Southern blot hybridization (Fig. 3). The 
three DNA bands formed during PCR strongly hybridi- 
zed with the Na”/H” exchanger-specific oligonucleotide 
probe. These results, the generation of PCR products of 
exactly the predicted size, the presence of a single NspV 
site. together with the hybridization results. positively 
identify the PCR products as amplified cDNA segments 
encoding the human Na’/H’ exchanger. 
We have described here a PCR method for studying 
the expression of Na’/H’ exchanger-specific mRNA in 
human blood cells. The amount of total RNA that can 
be prepared from resting human blood cells of a single 
donor is far below the quantity required for conventio- 
nal methods of mRNA detection, e.g. Northern blot- 
ting. Hence. for studies on the expression of Na’/H+ 
antiporter mRNA in human cells and tissue samples, a 
highly sensitive method is essential. 
The present report should also facilitate the develop- 
ment of a quantitative PCR assay for the detection of 
Na’/H’ exchanger mRNA in blood cells from subjects 
suffering from essential hypertension. These patients 
display an enhanced activity of Na’/H’ exchange in e.g. 
platelets and leukocytes [12.13] which may result from 
an increased number of active transport proteins. 
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